GleamWall
中文EN

ONC BeOne Medicines Ltd.

Pharmaceutical Preparations · Nasdaq · SEC CIK 1651308 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY32.9%
TTM net income YoY1,235.6%
TTM EPS YoY1,400.0%
Revenue 3-yr CAGR44.2%
Net income 3-yr CAGR—

Margins

Gross margin89.4%
Operating margin17.8%
Net margin13.9%
FCF margin21.9%
EBITDA margin20.2%

Returns

ROE18.4%
ROA10.5%
ROIC (approx.)158.2%
Asset turnover0.75x

Leverage & solvency

Liabilities / assets41.1%
Debt / equity0.18x
Current ratio3.55x
Interest coverage8.31x

Cash quality & payout

Operating cash flow / net income1.74x
Accruals ratio-7.7%
Payout ratio—
Capex / revenue2.1%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$5.34B$3.81B
Gross profit$4.67B$3.22B
R&D expense$2.15B$1.95B
SG&A expense$2.08B$1.83B
Operating income$447.14M-$568.20M
Interest expense$58.23M$21.80M
Pretax income$416.85M-$533.00M
Income tax$129.92M$111.78M
Net income$286.93M-$644.79M
EBITDA$588.82M-$396.44M
EPS (basic)0.20-0.47
EPS (diluted)0.19-0.47
Weighted avg. shares (diluted)1.47B1.37B
Balance sheet
Cash & equivalents$4.55B$2.64B
Receivables$865.08M$676.28M
Inventory$608.23M$494.99M
Current assets$6.23B$3.99B
PP&E, net$1.64B$1.58B
Intangibles$62.70M$51.09M
Total assets$8.19B$5.92B
Current liabilities$1.83B$2.21B
Short-term debt$57.29M$851.53M
Long-term debt$961.91M$166.48M
Total debt$1.02B$1.02B
Total liabilities$3.83B$2.59B
Shareholders' equity$4.36B$3.33B
Net debt-$3.53B-$1.62B
Shares outstanding1.44B1.39B
Cash flow statement
Operating cash flow$1.13B-$140.63M
Capital expenditure$185.84M$492.66M
Free cash flow$941.74M-$633.29M
Investing cash flow-$276.15M-$548.35M
Financing cash flow$1.06B$193.45M
Depreciation & amortization$141.69M$171.76M
Stock-based compensation$510.86M$441.62M

Free plan shows the latest 2 periods; Pro shows all 12 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.